Cargando…
Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase
Hepatocellular carcinoma (HCC) is one of the most aggressive malignant tumors, of which treatment options are limited especially in advanced stage. Bufalin, the major digoxin-like component of the traditional Chinese medicine Chansu, exhibits significant antitumor activities in hepatoma cells, but t...
Autores principales: | Yu, Zhuo, Feng, Hai, Sun, Xuehua, Zhuo, Yunhui, Li, Man, Zhou, Zhenhua, Huang, Lingying, Jiang, Yun, Zhu, Xiaojun, Zhang, Xin, Le, Fan, Zheng, Chao, Cheng, Alfred Szelok, Gao, Yueqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832857/ https://www.ncbi.nlm.nih.gov/pubmed/29497076 http://dx.doi.org/10.1038/s41598-018-22113-2 |
Ejemplares similares
-
Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling
por: Song, Haibin, et al.
Publicado: (2018) -
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
por: Yu, Zhuo, et al.
Publicado: (2022) -
Suppression of neointima formation by targeting β-catenin/TCF pathway
por: Williams, Helen, et al.
Publicado: (2016) -
Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
por: Tian, Yuan, et al.
Publicado: (2016) -
Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
por: Dou, Lei, et al.
Publicado: (2022)